Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 41, 2013 - Issue 1
Submit an article Journal homepage
538
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties

Yuzhu BianArtificial Cells and Organs Research Center, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, QC, Canada
,
Gao WeiArtificial Cells and Organs Research Center, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, QC, Canada
&
Thomas M. S. ChangArtificial Cells and Organs Research Center, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, QC, CanadaCorrespondence[email protected]
Pages 60-68 | Published online: 25 Jan 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Guoying Deng, Changzhe Chen, Junjie Zhang, Yue Zhai, Jingpeng Zhao, Anqi Ji, Yingjie Kang, Xijian Liu, Kefei Dou & Qiugen Wang. (2018) Se@SiO2 nanocomposites attenuate doxorubicin-induced cardiotoxicity through combatting oxidative damage. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 112-121.
Read now
Chen Guo & Thomas Ming Swi Chang. (2018) Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. Artificial Cells, Nanomedicine, and Biotechnology 46:7, pages 1349-1363.
Read now
Donglai Qi, Pei Wang, Chen Chen, Song Guo & Xiang Wang. (2016) Polymerization of modified diaspirin cross-linked hemoglobin (DCLHb) with 1,6-bismaleimic-hexane. Artificial Cells, Nanomedicine, and Biotechnology 44:4, pages 1069-1074.
Read now
Y. Z. Bian, C. Guo & T. M. S. Chang. (2016) Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at −80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C. Artificial Cells, Nanomedicine, and Biotechnology 44:1, pages 41-47.
Read now
Yuzhu Bian & Thomas Ming Swi Chang. (2015) A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. Artificial Cells, Nanomedicine, and Biotechnology 43:1, pages 1-9.
Read now
Wei Gao, Yuzhu Bian & Thomas M.S. Chang. (2013) Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase. Artificial Cells, Nanomedicine, and Biotechnology 41:4, pages 232-239.
Read now

Articles from other publishers (4)

Clara Coll-Satue, Shahana Bishnoi, Jiantao Chen & Leticia Hosta-Rigau. (2021) Stepping stones to the future of haemoglobin-based blood products: clinical, preclinical and innovative examples. Biomaterials Science 9:4, pages 1135-1152.
Crossref
Anna Wrobeln, Julia Laudien, Christoph Groß-Heitfeld, Jürgen Linders, Christian Mayer, Benjamin Wilde, Tanja Knoll, Dominik Naglav, Michael Kirsch & Katja B. Ferenz. (2017) Albumin-derived perfluorocarbon-based artificial oxygen carriers: A physico-chemical characterization and first in vivo evaluation of biocompatibility. European Journal of Pharmaceutics and Biopharmaceutics 115, pages 52-64.
Crossref
Thomas Ming Swi Chang. 2014. Principles of Tissue Engineering. Principles of Tissue Engineering 1059 1073 .
Thomas Ming Swi Chang. 2013. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics 3 26 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.